Rewalk Robotics Ltd
NASDAQ:RWLK
Rewalk Robotics Ltd
NASDAQ:RWLK
Price:
0.9652 USD
2.67%
Market Closed
Updated:
May 19, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-1.2
Current
0.8
Median
13.1
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-1.2
Enterprise Value
/
25.3m
EBITDA
-21.6m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| IL |
|
Rewalk Robotics Ltd
NASDAQ:RWLK
|
57.9m USD | -1.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.1B USD | 19 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.5B USD | 58.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.5B USD | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 14.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.7B USD | 31.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD | 18.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 18.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.7B USD | 27.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52B USD | 60.8 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
373.7B CNY | 28.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A
You don't have any saved screeners yet
